R. Clark

发表

Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial.

F. Hecht, J. Bartlett, K. Squires, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer.

C. Obasaju, C. Desch, S. Dakhil, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation.

M. Perry, C. Belani, G. Mills, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II multicenter randomized trial of induction weekly paclitaxel (P) administered in combination with carboplatin (C) followed by weekly maintenance P vs. observation for patients (pts.) with advanced & metastatic non-small cell lung cancer (NSCLC)

M. Perry, C. Belani, G. Mills, 2000 .

A Phase II Trial of Intermittent Leukocyte Interferon and High Dose Chlorambucil in the Treatment of Non-Hodgkin's Lymphoma Resistant to Conventional Therapy

N. Dimitrov, J. Axelson, R. H. Clark, 1989, American journal of clinical oncology.

Randomized, phase II study of two doses of pemetrexed as first-line chemotherapy for locally advanced or metastatic breast cancer (MBC): Clinical results and exploratory pharmacogenomic analysis.

N. Harbeck, C. Kaiser, A. Llombart-Cussac, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of Elderly Non–small Cell Lung Cancer Patients with Three Different Schedules of Weekly Paclitaxel in Combination with Carboplatin: Subanalysis of a Randomized Trial

S. Ramalingam, M. Perry, C. Belani, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.